Skip to Main Content

Paper Details

Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma.
Cancer Discov
44
2017
BRAF, BRAF Melanoma, BRAFV600, ERK1/2, IKBK, MEK, TBK1, cancer, cancer cell, drug, drug-resistant melanoma, five-feature, melanoma, melanoma tumor genomes, melanoma tumors, patient
Author NameAffiliation
Saurabh MendirattaThe University of Texas Southwestern Medical Center
Rahul K KolliparaEugene McDermott Center for Human Growth and Development, The University of Texas Southwestern Medical Center
Hailei ZhangThe Broad Institute of Harvard and Massachusetts Institute of Technology
Michael A DaviesThe University of Texas MD Anderson Cancer Center
Michael A DaviesThe University of Texas MD Anderson Cancer Center
Jennifer A WargoThe University of Texas MD Anderson Cancer Center
Jennifer A WargoThe University of Texas MD Anderson Cancer Center
Lynda ChinThe University of Texas MD Anderson Cancer Center
Georgina V LongMelanoma Institute, University of Sydney
Ralf KittlerEugene McDermott Center for Human Growth and Development, The University of Texas Southwestern Medical Center
Michael A WhiteThe University of Texas Southwestern Medical Center
  • 1 - 11

Datasets

Release 1.2